213 related articles for article (PubMed ID: 37495237)
1. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
Abhishek A; Tedeschi SK; Pascart T; Latourte A; Dalbeth N; Neogi T; Fuller A; Rosenthal A; Becce F; Bardin T; Ea HK; Filippou G; Fitzgerald J; Iagnocco A; Lioté F; McCarthy GM; Ramonda R; Richette P; Sivera F; Andrés M; Cipolletta E; Doherty M; Pascual E; Perez-Ruiz F; So A; Jansen TL; Kohler MJ; Stamp LK; Yinh J; Adinolfi A; Arad U; Aung T; Benillouche E; Bortoluzzi A; Dau J; Maningding E; Fang MA; Figus FA; Filippucci E; Haslett J; Janssen M; Kaldas M; Kimoto M; Leamy K; Navarro GM; Sarzi-Puttini P; Scirè C; Silvagni E; Sirotti S; Stack JR; Truong L; Xie C; Yokose C; Hendry AM; Terkeltaub R; Taylor WJ; Choi HK
Ann Rheum Dis; 2023 Oct; 82(10):1248-1257. PubMed ID: 37495237
[TBL] [Abstract][Full Text] [Related]
2. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.
Abhishek A; Tedeschi SK; Pascart T; Latourte A; Dalbeth N; Neogi T; Fuller A; Rosenthal A; Becce F; Bardin T; Ea HK; Filippou G; FitzGerald J; Iagnocco A; Lioté F; McCarthy GM; Ramonda R; Richette P; Sivera F; Andres M; Cipolletta E; Doherty M; Pascual E; Perez-Ruiz F; So A; Jansen TL; Kohler MJ; Stamp LK; Yinh J; Adinolfi A; Arad U; Aung T; Benillouche E; Bortoluzzi A; Dau J; Maningding E; Fang MA; Figus FA; Filippucci E; Haslett J; Janssen M; Kaldas M; Kimoto M; Leamy K; Navarro GM; Sarzi-Puttini P; Scirè C; Silvagni E; Sirotti S; Stack JR; Truong L; Xie C; Yokose C; Hendry AM; Terkeltaub R; Taylor WJ; Choi HK
Arthritis Rheumatol; 2023 Oct; 75(10):1703-1713. PubMed ID: 37494275
[TBL] [Abstract][Full Text] [Related]
3. [First classification criteria for diseases caused by calcium pyrophosphate deposition (CPPD)-Translation, explanation and assessment].
Braun J; Krekeler M; Kiltz U
Z Rheumatol; 2024 May; 83(4):306-315. PubMed ID: 38381191
[TBL] [Abstract][Full Text] [Related]
4. Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working Group.
Tedeschi SK; Becce F; Pascart T; Guermazi A; Budzik JF; Dalbeth N; Filippou G; Iagnocco A; Kohler MJ; Laredo JD; Smith SE; Simeone FJ; Yinh J; Choi H; Abhishek A
Arthritis Care Res (Hoboken); 2023 Apr; 75(4):825-834. PubMed ID: 35439343
[TBL] [Abstract][Full Text] [Related]
5. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
Cai K; Fuller A; Zhang Y; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; McCarthy GM; Rosenthal AK; Filippou G; Taylor WJ; Diaz-Torne C; Stamp LK; Edwards NL; Pascart T; Becce F; Nielsen SM; Tugwell P; Beaton D; Abhishek A; Tedeschi SK; Dalbeth N
Semin Arthritis Rheum; 2021 Aug; 51(4):946-950. PubMed ID: 34140183
[TBL] [Abstract][Full Text] [Related]
6. Calcium pyrophosphate deposition disease: clinical manifestations.
Ferrone C; Andracco R; Cimmino MA
Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
[TBL] [Abstract][Full Text] [Related]
7. Issues in CPPD Nomenclature and Classification.
Tedeschi SK
Curr Rheumatol Rep; 2019 Jul; 21(9):49. PubMed ID: 31346795
[TBL] [Abstract][Full Text] [Related]
8. Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease.
Cipolletta E; Abhishek A; Di Matteo A; Grassi W; Filippucci E
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36927850
[TBL] [Abstract][Full Text] [Related]
9. Review: Outcome measures in calcium pyrophosphate deposition.
Cai K; Tedeschi SK
Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101724. PubMed ID: 34799278
[TBL] [Abstract][Full Text] [Related]
10. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.
Tedeschi SK; Pascart T; Latourte A; Godsave C; Kundakci B; Naden RP; Taylor WJ; Dalbeth N; Neogi T; Perez-Ruiz F; Rosenthal A; Becce F; Pascual E; Andres M; Bardin T; Doherty M; Ea HK; Filippou G; FitzGerald J; Guitierrez M; Iagnocco A; Jansen TL; Kohler MJ; Lioté F; Matza M; McCarthy GM; Ramonda R; Reginato AM; Richette P; Singh JA; Sivera F; So A; Stamp LK; Yinh J; Yokose C; Terkeltaub R; Choi H; Abhishek A
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1649-1658. PubMed ID: 33973414
[TBL] [Abstract][Full Text] [Related]
11. [Performance of the 2015 ACR/EULAR classification criteria compared with other classification criteria for diagnosis of gout in Chinese patients].
Zhang QR; Wang Y; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):979-984. PubMed ID: 29263468
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed.
Frediani B; Filippou G; Falsetti P; Lorenzini S; Baldi F; Acciai C; Siagkri C; Marotto D; Galeazzi M; Marcolongo R
Ann Rheum Dis; 2005 Apr; 64(4):638-40. PubMed ID: 15769921
[TBL] [Abstract][Full Text] [Related]
13. Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition.
Falkowski AL; Jacobson JA; Kalia V; Meyer NB; Gandikota G; Yosef M; Thiele RG
PLoS One; 2020; 15(4):e0231508. PubMed ID: 32298308
[TBL] [Abstract][Full Text] [Related]
14. The crowned dens syndrome. Evaluation with CT imaging.
Scutellari PN; Galeotti R; Leprotti S; Ridolfi M; Franciosi R; Antinolfi G
Radiol Med; 2007 Mar; 112(2):195-207. PubMed ID: 17361376
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level.
Sirotti S; Terslev L; Filippucci E; Iagnocco A; Moller I; Naredo E; Vreju FA; Adinolfi A; Becce F; Hammer HB; Cazenave T; Cipolletta E; Christiansen SN; Delle Sedie A; Diaz M; Figus F; Mandl P; MacCarter D; Mortada MA; Mouterde G; Porta F; Reginato AM; Schmidt WA; Serban T; Wakefield RJ; Zufferey P; Sarzi-Puttini P; Zanetti A; Damiani A; Pineda C; Keen HI; D'Agostino MA; Filippou G;
Lancet Rheumatol; 2023 Aug; 5(8):e474-e482. PubMed ID: 38251579
[TBL] [Abstract][Full Text] [Related]
16. Describing calcium pyrophosphate deposition: undoing the tower of Babel!
Sirotti S; Terkeltaub R; Filippou G
Curr Opin Rheumatol; 2024 May; 36(3):241-250. PubMed ID: 38517340
[TBL] [Abstract][Full Text] [Related]
17. Cervical myelopathy due to subaxial calcium pyrophosphate dihydrate (CPPD) deposition with simultaneous asymptomatic crowned dens syndrome: two case reports.
Chang DG; Park JB; Jung HY; Seo KJ
BMC Musculoskelet Disord; 2020 Oct; 21(1):713. PubMed ID: 33129302
[TBL] [Abstract][Full Text] [Related]
18. [Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].
Tausche AK; Aringer M
Z Rheumatol; 2014 May; 73(4):349-57; quiz 358-9. PubMed ID: 24811359
[TBL] [Abstract][Full Text] [Related]
19. Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group.
Cai K; Fuller A; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; Abhishek A; Tedeschi S; Dalbeth N
Semin Arthritis Rheum; 2020 Aug; 50(4):719-727. PubMed ID: 32521326
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
Whelan MG; Hayashi K; Altwies H; Tedeschi SK
J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
